Antibodies under a microscope

Ab02155-10.3

Anti-Clcn4 [N222/6], Human IgG1, Fc Silent™, kappa

Description

Recombinant monoclonal antibody to Clcn4. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma N222/6. This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques.

Target

Clcn4

Target Alias Names

N222/6R, H(+)/Cl(-) exchange transporter 4, Chloride channel protein 4, ClC-4, Chloride transporter ClC-4

Isotype/Mimetic

IgG1

Animal-Derived Biomaterials Used

No

Sequence Available

No

Original Discovery Method

recombinantly reformatted hybridoma (from pre-2020 immunisation)

Original Discovery Information Provided On Datasheet

Yes

Antibody/Binder Origins

Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression